A Nanoparticle-Based Trivalent Vaccine Targeting the Glycan Binding VP8* Domains of Rotaviruses
Rotavirus causes severe gastroenteritis in children. Although vaccines are implemented, rotavirus-related diarrhea still claims ~200,000 lives annually worldwide, mainly in low-income settings, pointing to a need for improved vaccine tactics. To meet such a public health need, a P<sub>24</s...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/13/1/72 |
id |
doaj-6697629530ce4b00a2c5ed26a0693f9f |
---|---|
record_format |
Article |
spelling |
doaj-6697629530ce4b00a2c5ed26a0693f9f2021-01-07T00:05:09ZengMDPI AGViruses1999-49152021-01-0113727210.3390/v13010072A Nanoparticle-Based Trivalent Vaccine Targeting the Glycan Binding VP8* Domains of RotavirusesMing Xia0Pengwei Huang1Xi Jiang2Ming Tan3Division of Infectious Diseases, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH 45229, USADivision of Infectious Diseases, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH 45229, USADivision of Infectious Diseases, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH 45229, USADivision of Infectious Diseases, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH 45229, USARotavirus causes severe gastroenteritis in children. Although vaccines are implemented, rotavirus-related diarrhea still claims ~200,000 lives annually worldwide, mainly in low-income settings, pointing to a need for improved vaccine tactics. To meet such a public health need, a P<sub>24</sub>-VP8* nanoparticle displaying the glycan-binding VP8* domains, the major neutralizing antigens of rotavirus, was generated as a new type of rotavirus vaccine. We reported here our development of a P<sub>24</sub>-VP8* nanoparticle-based trivalent vaccine. First, we established a method to produce tag-free P<sub>24</sub>-VP8* nanoparticles presenting the VP8*s of P[8], P[<sup>4</sup>], and P[<sup>6</sup>] rotaviruses, respectively, which are the three predominantly circulating rotavirus P types globally. This approach consists of a chemical-based protein precipitation and an ion exchange purification, which may be scaled up for large vaccine production. All three P<sub>24</sub>-VP8* nanoparticle types self-assembled efficiently with authentic VP8*-glycan receptor binding function. After they were mixed as a trivalent vaccine, we showed that intramuscular immunization of the vaccine elicited high IgG titers specific to the three homologous VP8* types in mice. The resulted mouse sera strongly neutralized replication of all three rotavirus P types in cell culture. Thus, the trivalent P<sub>24</sub>-VP8* nanoparticles are a promising vaccine candidate for parenteral use against multiple P types of predominant rotaviruses.https://www.mdpi.com/1999-4915/13/1/72rotavirusP<sub>24</sub>-VP8* nanoparticlerotavirus vaccinerotavirus VP8*non-replicating rotavirus vaccinenorovirus P domain |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Ming Xia Pengwei Huang Xi Jiang Ming Tan |
spellingShingle |
Ming Xia Pengwei Huang Xi Jiang Ming Tan A Nanoparticle-Based Trivalent Vaccine Targeting the Glycan Binding VP8* Domains of Rotaviruses Viruses rotavirus P<sub>24</sub>-VP8* nanoparticle rotavirus vaccine rotavirus VP8* non-replicating rotavirus vaccine norovirus P domain |
author_facet |
Ming Xia Pengwei Huang Xi Jiang Ming Tan |
author_sort |
Ming Xia |
title |
A Nanoparticle-Based Trivalent Vaccine Targeting the Glycan Binding VP8* Domains of Rotaviruses |
title_short |
A Nanoparticle-Based Trivalent Vaccine Targeting the Glycan Binding VP8* Domains of Rotaviruses |
title_full |
A Nanoparticle-Based Trivalent Vaccine Targeting the Glycan Binding VP8* Domains of Rotaviruses |
title_fullStr |
A Nanoparticle-Based Trivalent Vaccine Targeting the Glycan Binding VP8* Domains of Rotaviruses |
title_full_unstemmed |
A Nanoparticle-Based Trivalent Vaccine Targeting the Glycan Binding VP8* Domains of Rotaviruses |
title_sort |
nanoparticle-based trivalent vaccine targeting the glycan binding vp8* domains of rotaviruses |
publisher |
MDPI AG |
series |
Viruses |
issn |
1999-4915 |
publishDate |
2021-01-01 |
description |
Rotavirus causes severe gastroenteritis in children. Although vaccines are implemented, rotavirus-related diarrhea still claims ~200,000 lives annually worldwide, mainly in low-income settings, pointing to a need for improved vaccine tactics. To meet such a public health need, a P<sub>24</sub>-VP8* nanoparticle displaying the glycan-binding VP8* domains, the major neutralizing antigens of rotavirus, was generated as a new type of rotavirus vaccine. We reported here our development of a P<sub>24</sub>-VP8* nanoparticle-based trivalent vaccine. First, we established a method to produce tag-free P<sub>24</sub>-VP8* nanoparticles presenting the VP8*s of P[8], P[<sup>4</sup>], and P[<sup>6</sup>] rotaviruses, respectively, which are the three predominantly circulating rotavirus P types globally. This approach consists of a chemical-based protein precipitation and an ion exchange purification, which may be scaled up for large vaccine production. All three P<sub>24</sub>-VP8* nanoparticle types self-assembled efficiently with authentic VP8*-glycan receptor binding function. After they were mixed as a trivalent vaccine, we showed that intramuscular immunization of the vaccine elicited high IgG titers specific to the three homologous VP8* types in mice. The resulted mouse sera strongly neutralized replication of all three rotavirus P types in cell culture. Thus, the trivalent P<sub>24</sub>-VP8* nanoparticles are a promising vaccine candidate for parenteral use against multiple P types of predominant rotaviruses. |
topic |
rotavirus P<sub>24</sub>-VP8* nanoparticle rotavirus vaccine rotavirus VP8* non-replicating rotavirus vaccine norovirus P domain |
url |
https://www.mdpi.com/1999-4915/13/1/72 |
work_keys_str_mv |
AT mingxia ananoparticlebasedtrivalentvaccinetargetingtheglycanbindingvp8domainsofrotaviruses AT pengweihuang ananoparticlebasedtrivalentvaccinetargetingtheglycanbindingvp8domainsofrotaviruses AT xijiang ananoparticlebasedtrivalentvaccinetargetingtheglycanbindingvp8domainsofrotaviruses AT mingtan ananoparticlebasedtrivalentvaccinetargetingtheglycanbindingvp8domainsofrotaviruses AT mingxia nanoparticlebasedtrivalentvaccinetargetingtheglycanbindingvp8domainsofrotaviruses AT pengweihuang nanoparticlebasedtrivalentvaccinetargetingtheglycanbindingvp8domainsofrotaviruses AT xijiang nanoparticlebasedtrivalentvaccinetargetingtheglycanbindingvp8domainsofrotaviruses AT mingtan nanoparticlebasedtrivalentvaccinetargetingtheglycanbindingvp8domainsofrotaviruses |
_version_ |
1724346899941556224 |